BfArM - Federal Institute for Drugs and Medical Devices

Navigation and service

Corrective action for LIAISON® Control Direct Renin, Diasorin

Product group In-vitro diagnostics - equipment / products for clinical chemistry
Reference 04236/13

Corrective action from Diasorin for LIAISON® Control Direct Renin due to increased control values. Customers were informed accordingly.

Corrective action for LIAISON® Control Direct Renin, Diasorin , Download_VeroeffentlichtAm_EN PDF, 575KB, File does not meet accessibility standards